236 related articles for article (PubMed ID: 26510954)
1. Alteration in 5-hydroxymethylcytosine-mediated epigenetic regulation leads to Purkinje cell vulnerability in ATM deficiency.
Jiang D; Zhang Y; Hart RP; Chen J; Herrup K; Li J
Brain; 2015 Dec; 138(Pt 12):3520-36. PubMed ID: 26510954
[TBL] [Abstract][Full Text] [Related]
2. Inactive Atm abrogates DSB repair in mouse cerebellum more than does Atm loss, without causing a neurological phenotype.
Tal E; Alfo M; Zha S; Barzilai A; De Zeeuw CI; Ziv Y; Shiloh Y
DNA Repair (Amst); 2018 Dec; 72():10-17. PubMed ID: 30348496
[TBL] [Abstract][Full Text] [Related]
3. Studying the cerebellar DNA damage response in the tissue culture dish.
Tzur-Gilat A; Ziv Y; Mittelman L; Barzilai A; Shiloh Y
Mech Ageing Dev; 2013 Oct; 134(10):496-505. PubMed ID: 23583690
[TBL] [Abstract][Full Text] [Related]
4. Cross-talk between DNA damage response and the central carbon metabolic network underlies selective vulnerability of Purkinje neurons in ataxia-telangiectasia.
Sun JK; Wong GC; Chow KH
J Neurochem; 2023 Aug; 166(4):654-677. PubMed ID: 37319113
[TBL] [Abstract][Full Text] [Related]
5. ATM is activated by ATP depletion and modulates mitochondrial function through NRF1.
Chow HM; Cheng A; Song X; Swerdel MR; Hart RP; Herrup K
J Cell Biol; 2019 Mar; 218(3):909-928. PubMed ID: 30642892
[TBL] [Abstract][Full Text] [Related]
6. Role of Tet1 and 5-hydroxymethylcytosine in cocaine action.
Feng J; Shao N; Szulwach KE; Vialou V; Huynh J; Zhong C; Le T; Ferguson D; Cahill ME; Li Y; Koo JW; Ribeiro E; Labonte B; Laitman BM; Estey D; Stockman V; Kennedy P; Couroussé T; Mensah I; Turecki G; Faull KF; Ming GL; Song H; Fan G; Casaccia P; Shen L; Jin P; Nestler EJ
Nat Neurosci; 2015 Apr; 18(4):536-44. PubMed ID: 25774451
[TBL] [Abstract][Full Text] [Related]
7. Targeting p38 mitogen-activated protein kinase signaling restores subventricular zone neural stem cells and corrects neuromotor deficits in Atm knockout mouse.
Kim J; Wong PK
Stem Cells Transl Med; 2012 Jul; 1(7):548-56. PubMed ID: 23197859
[TBL] [Abstract][Full Text] [Related]
8. MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system.
Mellén M; Ayata P; Dewell S; Kriaucionis S; Heintz N
Cell; 2012 Dec; 151(7):1417-30. PubMed ID: 23260135
[TBL] [Abstract][Full Text] [Related]
9. A global increase in 5-hydroxymethylcytosine levels marks osteoarthritic chondrocytes.
Taylor SE; Smeriglio P; Dhulipala L; Rath M; Bhutani N
Arthritis Rheumatol; 2014 Jan; 66(1):90-100. PubMed ID: 24449578
[TBL] [Abstract][Full Text] [Related]
10. Atm deficiency in the DNA polymerase β null cerebellum results in cerebellar ataxia and Itpr1 reduction associated with alteration of cytosine methylation.
Kim J; Kim K; Mo JS; Lee Y
Nucleic Acids Res; 2020 Apr; 48(7):3678-3691. PubMed ID: 32123907
[TBL] [Abstract][Full Text] [Related]
11. Ibuprofen prevents progression of ataxia telangiectasia symptoms in ATM-deficient mice.
Hui CW; Song X; Ma F; Shen X; Herrup K
J Neuroinflammation; 2018 Nov; 15(1):308. PubMed ID: 30400801
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress is responsible for deficient survival and dendritogenesis in purkinje neurons from ataxia-telangiectasia mutated mutant mice.
Chen P; Peng C; Luff J; Spring K; Watters D; Bottle S; Furuya S; Lavin MF
J Neurosci; 2003 Dec; 23(36):11453-60. PubMed ID: 14673010
[TBL] [Abstract][Full Text] [Related]
13. Ataxia telangiectasia: a review.
Rothblum-Oviatt C; Wright J; Lefton-Greif MA; McGrath-Morrow SA; Crawford TO; Lederman HM
Orphanet J Rare Dis; 2016 Nov; 11(1):159. PubMed ID: 27884168
[TBL] [Abstract][Full Text] [Related]
14. Evidence for the Deregulation of Protein Turnover Pathways in Atm-Deficient Mouse Cerebellum: An Organotypic Study.
Kim CD; Reed RE; Juncker MA; Fang Z; Desai SD
J Neuropathol Exp Neurol; 2017 Jul; 76(7):578-584. PubMed ID: 28535250
[TBL] [Abstract][Full Text] [Related]
15. Genetic ataxia telangiectasia porcine model phenocopies the multisystemic features of the human disease.
Beraldi R; Meyerholz DK; Savinov A; Kovács AD; Weimer JM; Dykstra JA; Geraets RD; Pearce DA
Biochim Biophys Acta Mol Basis Dis; 2017 Nov; 1863(11):2862-2870. PubMed ID: 28746835
[TBL] [Abstract][Full Text] [Related]
16. Loss of neuronal cell cycle control in ataxia-telangiectasia: a unified disease mechanism.
Yang Y; Herrup K
J Neurosci; 2005 Mar; 25(10):2522-9. PubMed ID: 15758161
[TBL] [Abstract][Full Text] [Related]
17. Abnormal development of Purkinje cells and lymphocytes in Atm mutant mice.
Borghesani PR; Alt FW; Bottaro A; Davidson L; Aksoy S; Rathbun GA; Roberts TM; Swat W; Segal RA; Gu Y
Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3336-41. PubMed ID: 10716718
[TBL] [Abstract][Full Text] [Related]
18. The appropriateness of the mouse model for ataxia-telangiectasia: neurological defects but no neurodegeneration.
Lavin MF
DNA Repair (Amst); 2013 Aug; 12(8):612-9. PubMed ID: 23731731
[TBL] [Abstract][Full Text] [Related]
19. TET1 contributes to neurogenesis onset time during fetal brain development in mice.
Kim H; Jang WY; Kang MC; Jeong J; Choi M; Sung Y; Park S; Kwon W; Jang S; Kim MO; Kim SH; Ryoo ZY
Biochem Biophys Res Commun; 2016 Mar; 471(4):437-43. PubMed ID: 26902115
[TBL] [Abstract][Full Text] [Related]
20. ATM immunolocalization in mouse neuronal endosomes: implications for ataxia-telangiectasia.
Kuljis RO; Chen G; Lee EY; Aguila MC; Xu Y
Brain Res; 1999 Sep; 842(2):351-8. PubMed ID: 10526131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
